MétaCan
Menu
Retour à la cohorte
Enregistrement W2148832585 · doi:10.1371/journal.pntd.0001962

Chagas Disease in Spain: Need for Further Public Health Measures

2012· article· en· W2148832585 sur OpenAlexaboutno aff
Miriam Navarro, Bárbara Navaza, Anne Guionnet, Rogelio López‐Vélez

Notice bibliographique

RevuePLoS neglected tropical diseases · 2012
Typearticle
Langueen
DomaineMedicine
ThématiqueTrypanosoma species research and implications
Établissements canadiensnon disponible
Organismes subventionnairesInstituto de Salud Carlos IIIFundación Mundo Sano
Mots-clésChagas diseaseTransmission (telecommunications)Latin AmericansTrypanosoma cruziPublic healthPopulationMedicineDiseaseNeglected tropical diseasesVector (molecular biology)Environmental healthBlood transfusionImmunologyBiologyPolitical scienceLawPathology

Résumé

récupéré en direct d'OpenAlex

Chagas disease, caused by the protozoa Trypanosoma cruzi, is endemic from Latin America and is considered a neglected tropical disease (NTD). An estimated 8 million people worldwide are infected, the country with the highest disease burden being Bolivia. Chagas disease has overcome borders, and it is no longer restricted to endemic countries. Nowadays, it can be found in the Unites States, Canada, Europe, Japan, and Australia, mainly due to mobility of population. Spain ranks second only to the United States in the list of countries receiving migrants from Latin America, and it is the European country with the highest prevalence of Chagas disease, therefore posing a challenge in terms of public health [1]. T. cruzi transmission is feasible in vector-free world regions. The main nonvectorial routes are congenital transmission, blood transfusion, and solid organ transplant. In fact, in Europe as well as in other nonendemic areas, there have been several cases of vertical transmission of T. cruzi and also transmission through infected tissue or blood products. Many nonendemic countries have not yet established official guidelines to avoid these routes [1], [2]. Mandatory screening of blood donors at risk for T. cruzi infection has been implemented since October 2005 in Spain targeting donors born in endemic areas, those whose mothers were born in endemic areas, and people who received blood transfusions in endemic areas [3]. Although not included in the Royal Decree, many blood banks also screen individuals who have resided in endemic areas for more than 2 months. In Spain, there is a national law that regulates the activity of tissue banks; moreover, the Spanish Society of Tropical Medicine and International Health has published a document in order to establish the guidelines to be followed in case a potential donor or a tissue or organ recipient could be affected by Chagas disease [4]. According to the recommendations of the WHO experts on the control and management of congenital Chagas disease, screening should be carried out during pregnancy to detect mothers who carry the infection and are at risk of transmitting the infection to their offspring. Furthermore, the WHO states that cases of congenital T. cruzi infection should be treated as soon as the diagnosis is confirmed using benznidazole or nifurtimox [5]. In Spain, systematic detection of congenital infection is not performed at the national level [1]; only two regions (Autonomous Community of Valencia and Catalonia) have a specific protocol. Currently, several scientific groups have drafted a clinical guide, which will be published shortly, about diagnosis, follow-up, and treatment of pregnant women and children with Chagas disease. Regarding treatment of infected newborns, the WHO recommendations are followed [5], using benznidazole as the first-line treatment option for Chagas disease in children and adults in Spain. Stocks of this drug ran out at the end of last year, which will result in Chagas disease becoming a NTD also in developed countries [6]. Until March 2012, this drug was only produced by the Brazilian state-owned laboratory LAFEPE. At that moment, the drug started to be produced also in Argentina through a private-public partnership led by Fundacion Mundo Sano. Benznidazole is available in Spain for all patients from the second half of November 2012. Estimating the burden of Chagas disease in nonendemic countries is crucial in order to plan preventive measures and to determine the resources for screening and treatment. Estimates are normally calculated according to the number of Latin Americans registered in each country and to the infection rates in their countries of origin. Thus, it is assumed that the prevalence of the infection in the host country is the same as that in the country of origin, this being the main limitation for achieving accurate estimations. In the past recent years, estimates on the expected number of migrants with T. cruzi infection have been carried out in Spain. The last one yields a figure of 48,000–86,000 cases, based on the Bolivians' infection rates of three studies performed only in two regions of Spain [7]. Being aware of the heterogeneous distribution of immigration, studies performed in different geographical regions of Spain were taken into account in this article in order to reach a comprehensive approach.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction distillée sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Apprise à partir de 10 348 étiquettes directes de Codex et de 10 348 étiquettes directes de Gemma. Le mode candidate est l'union des têtes enseignantes seuillées; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont ni des étiquettes humaines ni des étiquettes directes de modèles de pointe.

score de la tête « metaresearch » (Codex)0,000
score de la tête « metaresearch » (Gemma)0,003
Version: codex-gemma-dda1882f352aStatut de validation: machine_predicted_unvalidated
Catégories candidatesaucune
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Observationnel · Signal consensuel: Observationnel
GenreSignal candidat: Empirique · Signal consensuel: Empirique
Score de désaccord entre enseignants0,114
Score d'incertitude au seuil0,655

Scores Codex et Gemma par catégorie

CatégorieCodexGemma
Métarecherche0,0000,003
Méta-épidémiologie (sens strict)0,0000,000
Méta-épidémiologie (sens large)0,0000,000
Bibliométrie0,0000,001
Études des sciences et des technologies0,0000,000
Communication savante0,0000,000
Science ouverte0,0000,000
Intégrité de la recherche0,0000,000
Charge utile insuffisante (le modèle a refusé de juger)0,0000,000

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,089
Tête enseignante GPT0,328
Écart entre enseignants0,239 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule tête enseignante, pas un consensus.

Les modèles n’ont appliqué aucune catégorie : rien dans la taxonomie ne correspondait à ce travail.
Devis d'étudeObservationnel
Domainenon disponible
GenreEmpirique

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations76
Publié2012
Routes d'admission1
Résumé présentoui

Explorer davantage

Même revuePLoS neglected tropical diseasesMême sujetTrypanosoma species research and implicationsTravaux en français237 207